ArticleJournal of health economics and outcomes research2026
Cost-Effectiveness of Semaglutide 2.4 mg for Obesity Disease Management in Japan: A Lifetime Economic Modeling Study Incorporating Retreatment Scenarios.
Yuta Kamada et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.